The Contrast enhanced Mammography Screening Trial (CMIST) seeks to determine if CEM provides more accurate cancer detection compared to digital breast tomosynthesis for women with dense breasts.
After presenting an overview of the protocol, current status and planning, Dr. Jochelson will discuss the potential impact of this study on guidelines, patient care, workflow and economics.
The combination of US-ABUS, DBT, CEM offers both morphologic and functional information.
Pr. Luczynska will share her experience in the implementation and use of these technologies in a cancer center, the impact on patient care pathway, and her vision on the benefits of multi-modality integration, together with AI and radiomics.
Breast Magnetic Resonance Imaging (MRI) has become a routine breast examination in breast diagnosis. Abbreviated protocols and diffusion-weighted imaging (DWI) are now standard practices.
After a refresher on the techniques, the speaker will present the findings of his recent study, which demonstrate the efficacy of using combined ultrafast and DWI protocols.